Global Cheek Augmentation Market Size study & Forecast, by Product (Derma Fillers, Implant, Others) by End Use (Hospitals, Clinics, Others) and Regional Analysis, 2023-2030

Global Cheek Augmentation Market Size study & Forecast, by Product (Derma Fillers, Implant, Others) by End Use (Hospitals, Clinics, Others) and Regional Analysis, 2023-2030

Global Cheek Augmentation Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2023-2030. Cheek augmentation is a cosmetic procedure that aims to enhance the appearance of the cheeks by adding volume and definition. It involves the use of various techniques to increase the size and fullness of the cheeks, such as the use of implants, injectable fillers, or fat grafting. Cheek augmentation can help to address several aesthetic concerns, such as a lack of definition in the cheekbones, flat or sunken cheeks, or an asymmetrical appearance. The procedure can be customized to meet the specific needs and goals of each patient and can be performed alone or in combination with other facial procedures for more comprehensive rejuvenation. The Cheek Augmentation Market is expanding because of factors such as increasing number of plastic surgery procedures and the rising incidence of accidents and facial injuries.

The American Society of Plastic Surgeons reports that only female patients underwent 108,189 procedures for cheek implants in 2020. Additionally, there were around 108,189 male cheek implant treatments. In the same year, about 216,350 and 28,638 facelift procedures were carried out on women and men, respectively. The cheek augmentation market has been significantly influenced by the ageing population. People's skin becomes less elastic as they age, which causes drooping cheeks and other ageing symptoms. Cheek augmentation is a desirable procedure for older people because it can help them regain a more youthful appearance. A survey conducted by WebMD LLC in November 2021 found that almost 75% of people over 65 are receptive to having cosmetic surgery. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus, the rising number of plastic surgeries perform and the rising old age population across the globe is fostering market growth. However, the high cost of Cheek Augmentation stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cheek Augmentation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing disease prevalence, and the rising number of plastic surgeries, in the region. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Allergan, Inc.
GALDERMA
Merz Pharma
Sientra, Inc.
Johnson & Johnson Private Limited.
Sinclair Aesthetics
Anika Therapeutics, Inc.
Cutera Inc.
Stryker Corporation
Hanson Medical Inc.

Recent Developments in the Market:
 In January 2023, Allergan Aesthetics announced the launch of JUVÉDERM® VOLUX™ XC. JUVÉDERM® VOLUMA® XC injectable gel is intended for deep injection in the cheek area to restore volume lost with ageing, as well as for chin augmentation to enhance the chin profile in individuals. For patients over the age of 21 who have moderate to a severe loss of jawline definition, the long-lasting hyaluronic acid (HA) filler is accessible in cosmetic clinics.
 In June 2021, Galderma announced that U.S. Food and Drug Administration (FDA) has approved its Restylane® Contour product used for cheek augmentation as well as correction of midface contour deficiencies occurring in adults aged over 21. Galderma's new Restylane Contour dermal filler, which uses XpresHAn TechnologyTM to produce a contour for the cheekbones, is the brand's first and exclusive product using hyaluronic acid (HA) in the US. Natural and dynamic motion expression is made possible by smooth, skin-absorbing injectable gel made using XpresHAn TechnologyTM's unique manufacturing process.

Global Cheek Augmentation Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, End Use, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Derma Fillers
Implant
Others
By End Use:
Hospitals
Clinics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned

Allergan, Inc.
GALDERMA
Merz Pharma
Sientra, Inc.
Johnson & Johnson Private Limited.
Sinclair Aesthetics
Anika Therapeutics, Inc.
Cutera Inc.
Stryker Corporation
Hanson Medical Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.